Hall Jason, Noyce Peter, Cantrill Judith
School of Pharmaceutical Sciences, University of Manchester, Manchester, UK.
Br J Community Nurs. 2008 Nov;13(11):507-13. doi: 10.12968/bjcn.2008.13.11.31522.
This paper describes how district nurses decide what products to start prescribing and explores the reasons why prescribing patterns change. It is based on semi-structured interviews with fourteen nurses from one primary care trust. The first products prescribed immediately following qualification depended on the route taken to becoming a prescriber. These were either the same products they had been using before qualifying as a prescriber or if prescribing was included with their district nurse training then it was the same products that their mentor prescribed. The two drivers for changes in prescribing patterns were patients, whose current therapy was ineffective, and products, where patients were selected to try new products on. Representatives from the pharmaceutical industry and fellow nurses had the greatest influence on product selection for those prescribers that changed their prescribing. The nurse's own experience had the greatest impact on the decision to continue prescribing a new product.
本文描述了社区护士如何决定开始开具哪些产品的处方,并探讨了处方模式发生变化的原因。它基于对来自一个初级保健信托机构的14名护士的半结构化访谈。取得资格后立即开具的首批产品取决于成为开处方者所走的途径。这些产品要么是她们在取得开处方资格之前一直在使用的产品,要么如果开处方包含在她们的社区护士培训中,那么就是她们的带教老师所开具的相同产品。处方模式变化的两个驱动因素是患者(其当前治疗无效)和产品(选择患者试用新产品)。对于那些改变处方的开处方者来说,制药行业的代表和同行护士对产品选择的影响最大。护士自身的经验对继续开具新产品的决定影响最大。